Age-related deficits of central muscarinic cholinergic receptor function in the mouse: partial restoration by chronic piracetam treatment

Neurobiol Aging. 1992 Jan-Feb;13(1):39-44. doi: 10.1016/0197-4580(92)90006-j.

Abstract

The effect of aging on muscarinic cholinergic receptor function in dissociated cell aggregates of the mouse brain was investigated using two biochemical models, i.e., carbachol-induced accumulation of inositol monophosphates and carbachol-induced desensitization of muscarinic cholinergic receptors as measured by the sequestration of specific 3H-N-methyl-scopolamine binding. While aging strongly reduced carbachol-induced inositol monophosphate accumulation, desensitization was not affected in the brains of aged animals. Chronic treatment of aged mice with the nootropic drug piracetam (500 mg/kg daily PO) significantly elevated the agonist-induced accumulation of inositol monophosphates possibly by increasing the available number of muscarinic cholinergic receptors not being in a desensitized state. The results support the hypothesis that nootropics like piracetam might act in part by restoring age-related deficits of central muscarinic cholinergic receptor function.

MeSH terms

  • Aging / physiology*
  • Animals
  • Brain / cytology
  • Brain / metabolism
  • Carbachol / pharmacology
  • Down-Regulation / drug effects
  • Female
  • Kinetics
  • Lipid Metabolism
  • Mice
  • N-Methylscopolamine
  • Phosphatidylinositols / metabolism
  • Piracetam / pharmacology*
  • Receptors, Muscarinic / drug effects
  • Receptors, Muscarinic / physiology*
  • Scopolamine Derivatives / metabolism

Substances

  • Phosphatidylinositols
  • Receptors, Muscarinic
  • Scopolamine Derivatives
  • Carbachol
  • N-Methylscopolamine
  • Piracetam